These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

331 related items for PubMed ID: 17631027

  • 21. Successful treatment of mixed-type autoimmune hemolytic anemia with rituximab in a child following liver transplantation.
    Haller W, Hind J, Height S, Mitry R, Dhawan A.
    Pediatr Transplant; 2010 May; 14(3):E20-5. PubMed ID: 19254271
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Longterm clinical and immunological effects of anti-CD20 treatment in patients with refractory systemic lupus erythematosus.
    Lindholm C, Börjesson-Asp K, Zendjanchi K, Sundqvist AC, Tarkowski A, Bokarewa M.
    J Rheumatol; 2008 May; 35(5):826-33. PubMed ID: 18398943
    [Abstract] [Full Text] [Related]

  • 24. Successful treatment with rituximab for autoimmune hemolytic anemia concomitant with proliferation of Epstein-Barr virus and monoclonal gammopathy in a post-nonmyeloablative stem cell transplant patient.
    Endo T, Nakao S, Koizumi K, Nishio M, Fujimoto K, Sakai T, Kumano K, Obara M, Koike T.
    Ann Hematol; 2004 Feb; 83(2):114-6. PubMed ID: 14513283
    [Abstract] [Full Text] [Related]

  • 25. Anti-CD20 monoclonal antibody (Rituximab) for life-threatening hemolytic-uremic syndrome.
    Yassa SK, Blessios G, Marinides G, Venuto RC.
    Clin Transplant; 2005 Jun; 19(3):423-6. PubMed ID: 15877809
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Rituximab is an effective and safe therapeutic alternative in adults with refractory and severe autoimmune hemolytic anemia.
    Peñalver FJ, Alvarez-Larrán A, Díez-Martin JL, Gallur L, Jarque I, Caballero D, Díaz-Mediavilla J, Bustelos R, Fernández-Aceñero MJ, Cabrera JR, Multi-institutional Retrospective Study on the use of rituximab in refractory AIHA.
    Ann Hematol; 2010 Nov; 89(11):1073-80. PubMed ID: 20526716
    [Abstract] [Full Text] [Related]

  • 28. Successful treatment of transplant-associated microangiopathy with rituximab.
    Marr H, McDonald EJ, Merriman E, Smith M, Mangos H, Stoddart C, Ganly P.
    N Z Med J; 2009 Apr 03; 122(1292):72-4. PubMed ID: 19448776
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. B cell-targeted therapy with rituximab and autoimmune neuromuscular disorders.
    Stübgen JP.
    J Neuroimmunol; 2008 Nov 15; 204(1-2):1-12. PubMed ID: 18783837
    [Abstract] [Full Text] [Related]

  • 31. Clinical significance of serologic markers related to red blood cell autoantibodies production after red blood cell transfusion-severe autoimmune hemolytic anemia occurring after transfusion and alloimmunization: successful treatment with rituximab.
    Sigler E, Shvidel L, Yahalom V, Berrebi A, Shtalrid M.
    Transfusion; 2009 Jul 15; 49(7):1370-4. PubMed ID: 19374728
    [Abstract] [Full Text] [Related]

  • 32. Anti-B- cell-directed immunotherapy (rituximab) in the treatment of refractory pemphigus--an update.
    Arin MJ, Hunzelmann N.
    Eur J Dermatol; 2005 Jul 15; 15(4):224-30. PubMed ID: 16048747
    [Abstract] [Full Text] [Related]

  • 33. Successful unrelated umbilical cord blood transplantation in a child with Omenn's syndrome.
    Benito A, Diaz MA, Alonso F, Fontán G, Madero L.
    Pediatr Hematol Oncol; 1999 Jul 15; 16(4):361-6. PubMed ID: 10407874
    [Abstract] [Full Text] [Related]

  • 34. A review of rituximab in cutaneous medicine.
    Scheinfeld N.
    Dermatol Online J; 2006 Jan 27; 12(1):3. PubMed ID: 16638371
    [Abstract] [Full Text] [Related]

  • 35. Rituximab for warm-type idiopathic autoimmune hemolytic anemia: a retrospective study of 11 adult patients.
    D'Arena G, Califano C, Annunziata M, Tartarone A, Capalbo S, Villani O, Amendola G, Pietrantuono G, Ferrara F, Pinto A, Musto P, D'Arco AM, Cascavilla N.
    Eur J Haematol; 2007 Jul 27; 79(1):53-8. PubMed ID: 17532766
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Autoimmune hemolytic anemia].
    Berentsen S, Sundic T, Hervig T, Tjønnfjord GE.
    Tidsskr Nor Laegeforen; 2009 Nov 05; 129(21):2226-31. PubMed ID: 19898570
    [Abstract] [Full Text] [Related]

  • 40. Safety, efficacy, and immune reconstitution after rituximab therapy in pediatric patients with chronic or refractory hematologic autoimmune cytopenias.
    Rao A, Kelly M, Musselman M, Ramadas J, Wilson D, Grossman W, Shenoy S.
    Pediatr Blood Cancer; 2008 Apr 05; 50(4):822-5. PubMed ID: 17570702
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.